VDR and breast carcinoma: Besides its physiological role, 1,25(OH)2D3 is a potent inhibitor of breast cancer (BC) cell growth, exerting its anticancer effect through the binding of VDR, which induces the activation of a series of genes involved in cell growth, differentiation and apoptosis [8–9].